Data / New clinical trials / China
New clinical trials in China: 14,773 since Nov 2024
The full list. New clinical trials with a site in China: 14,773 rows for $227.73, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 586 rows a month. The new rows come each week by email, $29.30 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/china, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
14,773 clinical studies with a site in China were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 3,931 have an industry sponsor and 10,644 are recruiting or about to. The newest, NCT07927075, was posted on November 9, 2026: Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression (Sir Run Run Shaw Hospital).
The request: Every new clinical trial with a site in China, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 14,773New trials
- 3,931Industry sponsored
- 10,644Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 14,773, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07927075 | Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression | Sir Run Run Shaw Hospital | Phase 2/3 | Enrolling by invitation | Colorectal Cancer | 17 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07927049 | Evaluating the Efficacy of Chidamide in the Treatment of Initial Unresectable Metastatic Colorectal Cancer With High Expression of SULF1 | Sir Run Run Shaw Hospital | Phase 2/3 | Enrolling by invitation | Colorectal Cancer | 126 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07926854 | Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in... | China National Center for Cardiovascular Diseases | Not applicable | Not yet recruiting | Atrial Fibrillation (AF) | 294 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07926672 | Artificial Intelligence-Assisted Imaging for Diagnosis and Management of Focal Liver Lesions | Sun Yat-sen University | Not applicable | Recruiting | Focal Liver Lesions | 10,000 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07926607 | Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia | Second Affiliated Hospital of Nanchang University | Phase 1/2 | Not yet recruiting | Acute Myeloblastic Leukemia | 55 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07926438 | 40 Hz Audio-Visual Stimulation Therapy for AD | The First Affiliated Hospital of Xiamen University | Not applicable | Not yet recruiting | Alzheimer's Disease Related Dementia | 50 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925866 | Tislelizumab Combined With Tofacitinib and Docetaxel for NSCLC After Failure of First-Line Immunotherapy | Anhui Provincial Hospital | Phase 2 | Recruiting | Patients With Locally Advanced or Metastatic NSCLC Who Have Failed First-line Immunotherapy | 39 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925684 | Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese Patients | Jianbo Wu | Not applicable | Recruiting | Procedural Sedation and Analgesia, Obesity & Overweight | 120 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925671 | Jaktinib in Ruxolitinib-Treatment Failure Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study | Affiliated Hospital of Nantong University | Observational | Not yet recruiting | Myeloproliferative Neoplasms/Myelofibrosis | 80 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925632 | A Multicenter, Prospective, Observational Study of Jaktinib in Newly Diagnosed Myelofibrosis | Affiliated Hospital of Nantong University | Observational | Not yet recruiting | Myeloproliferative Neoplasms/Myelofibrosis | 80 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925554 | Interferon-α Maintenance in Favorable-Risk AML | Peking University People's Hospital | Phase 2 | Recruiting | AML (Acute Myeloid Leukemia) | 30 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925216 | A Pharmacokinetic Study of Budesonide Delayed Release Tablet D23A (D23) in Healthy Chinese Participants Under Fasting Conditions | Triastek, lnc. | Phase 1 | Active not recruiting | IgA Nephropathy (IgAN) | 18 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925190 | A Phase III Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) Patients | Beijing InnoCare Pharma Tech Co., Ltd. | Phase 3 | Not yet recruiting | Acute Myeloblastic Leukaemia | 318 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925125 | Artificial Intelligence-Assisted 4D Dynamic Long-Axial PET Imaging for the Detection of Early Pancreatic Cancer Lesions | Ruijin Hospital | Observational | Recruiting | Pancreas Carcinoma, PDAC - Pancreatic Ductal Adenocarcinoma | 50 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925047 | Individualized Temporal Interference Stimulation for Reward Processing in Late-Life Depression | Beijing HuiLongGuan Hospital | Not applicable | Not yet recruiting | Major Depressive Disorder (MDD | 70 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07925021 | A Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal Carcinoma | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 3 | Recruiting | Previously Systemic Treatment-Naive Recurrent or Metastatic Nasopharyngeal Carcinoma | 424 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924956 | Explore the Weight Loss Effect of Amway "BODY TRIMMER" | Amway (China) R&D Center | Not applicable | Recruiting | Abdominal Obesity | 110 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924917 | Individualized Temporally Interfering Electrical Stimulation in Major Depressive Disorder | Tianjin Medical University General Hospital | Not applicable | Recruiting | Major Depressive Disorder (MDD) | 75 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924748 | Balance Training and Resting Brain Activity in Knee Osteoarthritis: A Randomized Controlled Trial | Qingdao Municipal Hospital | Not applicable | Completed | Osteoarthritis, Knee | 74 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924696 | Effect of AI-Assisted Hand Hygiene Training on Hand Hygiene Competency in Newly Hired Workers | Sir Run Run Shaw Hospital | Not applicable | Completed | Healthy Adult Participants | 260 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924683 | Efficacy and Circuit Mechanisms of Noninvasive Brain-Computer Interface Therapy for Upper-Extremity Motor Function in Patients With... | Xuanwu Hospital, Beijing | Not applicable | Not yet recruiting | Stroke, Rehabilitation, Brain Computer Interface | 38 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924657 | Acoustic Stimulation During Sleep for Alzheimer's Disease | Xuanwu Hospital, Beijing | Not applicable | Recruiting | Alzheimer s Disease | 40 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924644 | AI-Based Digital Pathology Model for Predicting Treatment Response and Prognosis in mHSPC | Xiangya Hospital of Central South University | Not applicable | Active not recruiting | Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer) | 1,115 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924527 | Predicting Benefit From Anthracycline-Free Adjuvant Chemotherapy in High-Risk HER2-Negative Breast Cancer | Peking Union Medical College Hospital | Observational | Active not recruiting | Breast Neoplasms, HER2-negative Breast Cancer | 100 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924501 | AI-ECHO Hemodynamic Phenotyping in Septic Shock | Second Affiliated Hospital of Guangzhou Medical University | Observational | Not yet recruiting | Sepsis, Septic Shock, Septic Cardiomyopathy | 240 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924488 | TCM Fumigation Care for Uremic Refractory Pruritus During Hemoperfusion | Second Affiliated Hospital of Nanchang University | Not applicable | Active not recruiting | Refractory Pruritus | 80 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924449 | KRAS G12D-specific Immune Effector Cells Targeting KRAS G12D-positive Solid Tumors | Shenzhen Geno-Immune Medical Institute | Not applicable | Not yet recruiting | Advanced Malignant Tumors With KRAS G12D Mutation | 30 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924306 | Effects of Biased Opioid Agonists on Gastrointestinal Recovery After Gynecologic Laparoscopic Surgery | Hainan Medical College | Phase 4 | Recruiting | Gynecologic Laparoscopic Surgery, Postoperative Gastrointestinal Dysfunction | 212 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924280 | Clinical Study on Tubeless Anesthesia for Minimally Invasive Surgery Combined With Ablation in Patients With High-Risk Ground-Glass Nodules | The First Affiliated Hospital of Guangzhou Medical University | Not applicable | Recruiting | Tubeless Anesthesia, MWA (Microwave Ablation), Ground-glass Nodules (GGNs), Lung, Simultaneous, VATS (Video-assisted... | 80 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924189 | Association of Psychological Distress With Clinical Outcomes in Patients With Digestive System Cancers | Xuanwu Hospital, Beijing | Observational | Active not recruiting | Psychological Distress, Pancreatic Cancer, Colorectal Cancer, Gastric Cancer | 100 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07924176 | Robot-Assisted Bronchoscopy for Lung Lesion Biopsy and Ablation | Shanghai Pulmonary Hospital, Shanghai, China | Not applicable | Completed | Pulmonary Lesions | 85 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07923968 | The Preventive Efficacy of ULP for Stress Urinary Incontinence After Pelvic Organ Prolapse Surgery | Peking University People's Hospital | Not applicable | Not yet recruiting | Stress Urinary Incontinence in Women, Pelvic Organ Prolapse (POP) | 236 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923851 | A Trial Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Palmoplantar Pustulosis | Guangdong Hengrui Pharmaceutical Co., Ltd | Phase 2 | Not yet recruiting | Palmoplantar Pustulosis of Adults | 40 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923838 | Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease | Shanghai Jiao Tong University School of Medicine | Phase 1/2 | Active not recruiting | Parkinson Disease (PD) | 9 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923812 | Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study | Fudan University | Observational | Recruiting | Alzheimer's Disease (AD) | 3,000 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923786 | Clinical Study of 68Ga-labeled Novel EPHA2 Cyclic Peptides PET/CT for Imaging of Solid Tumors | The First Affiliated Hospital of Soochow University | Early phase 1 | Active not recruiting | Solid Tumor Malignancies | 12 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923578 | Pharmacokinetics, Safety and Tolerability of Single Sequential and Multiple Intravenous Infusions of Ulinastatin for Injection in Healthy... | Techpool Bio-Pharma Co., Ltd. | Phase 1 | Not yet recruiting | Healthy Participants, Ulinastatin | 40 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923396 | GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis | Ruijin Hospital | Phase 1 | Not yet recruiting | Gastric Cancer (GC) | 10 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923357 | A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 2 | Not yet recruiting | Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, T2DM | 364 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923344 | The Impact of Fast-Track Anesthesia on Postoperative Neurocognitive Function in Patients Undergoing Cardiac Surgery | Second Affiliated Hospital of Nanchang University | Observational | Recruiting | Delirium - Postoperative, Cardiac Surgery | 320 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923214 | A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors | Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | Phase 1 | Recruiting | Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors | 30 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923058 | Clinical Trial of SEEG for Drug-resistant Epilepsy | Beijing Pins Medical Co., Ltd | Not applicable | Not yet recruiting | Drug-Resistant Epilepsy | 99 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922954 | Thymosin Alpha 1 and IgM Levels in Sepsis | Southeast University, China | Phase 4 | Active not recruiting | Sepsis, Septic Shock | 36 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922902 | Automated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCT | zhaoxiaohui | Not applicable | Not yet recruiting | Cancer, Malignant Neoplasms, Radiotherapy | 62 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922798 | A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy... | The United Bio-Technology (Hengqin) Co., Ltd. | Phase 1 | Not yet recruiting | Overweight , Obesity | 60 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922603 | Effects of Seated Exercise on Fatigue Associated With Prolonged Sitting During High-Speed Rail Travel | Aiyoudong Children and Youth Sports Health Research Institute | Not applicable | Completed | Sedentary Behavior, Fatigue, Prolonged Sitting | 120 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922538 | Human Bioequivalence Study of Letermovir Tablets | The Affiliated Hospital of Qingdao University | Phase 1 | Completed | Tmax*(h), Cmax(ng/mL), AUC0-t(ng∙h/mL), AUC0-∞(ng∙h/mL), λz(h-1), AUC_%Extrap(%) | 56 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922330 | A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These... | AstraZeneca | Phase 3 | Not yet recruiting | Obesity, Overweight, Type 2 Diabetes Mellitus | 330 | China, India | clinicaltrials.gov |
| November 6, 2026 | NCT07922096 | A First-in-human Study of SMP-656 in Subjects With Locally Advanced/ Metastatic HER2 Expressing or Mutated Solid Tumors | Chengdu SciMount Pharmatech Co., Ltd. | Phase 1 | Completed | HER2-Expressing Advanced Solid Tumors, HER2-Mutated Advanced Solid Tumors, Metastatic Solid Tumors | 35 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922070 | A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Conditions. | The Affiliated Hospital of Qingdao University | Phase 1 | Completed | Bipolar I Disorder | 36 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922044 | Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Critically Ill Patients Requiring Mechanical Ventilation | 120 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07921732 | Prospective, Multicenter, Randomized Controlled Phase III Trial of Biological Mesh for Alimentary Tract Reconstruction in Digestive Surgery | Nanfang Hospital, Southern Medical University | Not applicable | Recruiting | Digestive System Surgical Procedures, Anastomosis, Surgical, Postoperative Hemorrhage, Anastomotic Leaks | 144 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07921225 | Teaching Effects of VTS Curriculum in Chinese Medical Students | Peking Union Medical College Hospital | Not applicable | Completed | Observation and Diagnostic Skills of Medical Students | 67 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920939 | Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | Not yet recruiting | Type 2 Diabetes | 450 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920861 | A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight... | Huabo Biopharm Co., Ltd. | Phase 1 | Recruiting | Psoriasis, Ankylosing Spondylitis | 90 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920835 | A Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT Imaging | Hexin (Suzhou) Pharmaceutical Technology Co., Ltd | Phase 2 | Recruiting | Soft Tissue Sarcoma | 60 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920822 | Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors | Hexin (Suzhou) Pharmaceutical Technology Co., Ltd | Phase 1 | Enrolling by invitation | Soft Tissue Sarcoma, Non-small Cell Lung Cancer | 12 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920796 | Thiotepa + TBI + Fludarabine + Etoposide for Allo-HSCT in Patients With R/R or High-risk Acute Leukemia | Guangdong Second Provincial General Hospital | Phase 2 | Enrolling by invitation | Acute Leukemia, High Risk, Acute Leukemia Refractory, Acute Leukemia, Relapsed | 50 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920783 | A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants | Gan & Lee Pharmaceuticals. | Phase 1 | Not yet recruiting | Atopic Dermatitis | 124 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920770 | Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer | Fujian Medical University Union Hospital | Observational | Recruiting | Rectal Neoplasms | 100 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920757 | Multi-omics Profiling of Relapsed Extranodal Natural Killer (NK)/T-cell Lymphoma | Fujian Medical University Union Hospital | Observational | Active not recruiting | Extranodal NK/T-cell Lymphoma, Nasal Type | 50 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920744 | The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis | Fifth Affiliated Hospital, Sun Yat-Sen University | Observational | Recruiting | Liver Cirrhosis, Gastroesophageal Varices | 364 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920731 | A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer | Fudan University | Phase 2 | Enrolling by invitation | Pancreatic Cancer Metastatic | 45 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07920692 | Integrated Medicine for Sepsis: An RCT With Phenotyping | Henan University of Traditional Chinese Medicine | Not applicable | Not yet recruiting | Sepsis | 320 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920640 | Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention | Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | Phase 2 | Not yet recruiting | Diabetes Mellitus, Type 2 | 150 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920250 | Pre-Radiotherapy n-6/n-3 Fatty Acid Ratio Predicts Severe Oral Mucositis in Nasopharyngeal Carcinoma | Affiliated Hospital of Guangdong Medical University | Phase 2 | Completed | Nasopharyngeal Carcinoma (NPC), Radiation-induced Oral Mucositis, Head and Neck Neoplasms | 210 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920224 | Candonilimab Combined With Fruquintinib and Paclitaxel Albumin-Bound as Second-Line Treatment for Advanced Gastric or Gastro-esophageal... | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Recruiting | Stomach Neoplasms | 59 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920172 | Clinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1/2 | Recruiting | Herpes Zoster | 500 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920133 | Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD) | Sir Run Run Shaw Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Residual Inflammatory Risk | 1,768 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920094 | Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of... | Sir Run Run Shaw Hospital | Not applicable | Recruiting | Breast Cancer | 422 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920055 | Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon... | Sir Run Run Shaw Hospital | Not applicable | Not yet recruiting | Coronary In-stent Restenosis, Coronary Artery Disease | 106 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919977 | Romiplostim for Platelet Engraftment After Haploidentical or Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation | Liping Dou | Phase 2 | Recruiting | Hematologic Diseases | 120 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919951 | RAPID for Unresectable Colorectal Liver Metastases | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Not yet recruiting | Colorectal Liver Metastases (CRCLM), Colorectal Neoplasms | 10 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919717 | NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC | Shanghai Zhongshan Hospital | Phase 2 | Not yet recruiting | Hepatocellular Carcinoma (HCC), Recurrent Hepatocellular Cancer | 35 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919704 | AI-Assisted Differentiation of Pancreatic Cystic Lesions Using EUS Images and Clinical Features | Ruijin Hospital | Observational | Not yet recruiting | Pancreatic Mucinous Cystic Neoplasm, Pancreatic Serous Cystic Neoplasm, Pancreatic Pseudocyst | 400 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919470 | Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT | Peking University People's Hospital | Not applicable | Not yet recruiting | Acute Lymphoblastic Leukemia, Hematopoietic Stem Cell Transplantation | 180 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919431 | Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer | Peking Union Medical College Hospital | Observational | Enrolling by invitation | Cervical Cancer Screening | 100 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919418 | A Patient-Derived 3D Bioprinted Colorectal Cancer-Stroma-Immune Triad Model Uncovers Microenvironmental Mechanisms of Chemoresistance and... | Peking Union Medical College Hospital | Observational | Recruiting | Colorectal Cancer | 60 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919119 | Risk Stratification Value of Deep NGS-MRD Detection in Acute Myeloid Leukemia Patients After Allo-HSCT | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Measurable Residual Disease, Acute Myeloid Leukemia | 169 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918976 | Effects of Inhaled Nitric Oxide on Sublingual Microcirculation in Patients With Right Ventricular Dysfunction After Cardiac Surgery | Southeast University, China | Phase 2 | Completed | Cardiac Surgery Intensive Care Treatment, Pulmonary Hypertension, Right Ventricular (RV) Dysfunction | 60 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918937 | Multi-center Study of Three-Dimensional Transesophageal Echocardiography in Patients With Secondary Mitral Regurgitation | First Hospital of China Medical University | Observational | Not yet recruiting | Mitral Valve Insufficiency | 2,400 | China, Hong Kong, Taiwan | clinicaltrials.gov |
| November 5, 2026 | NCT07918794 | Comparison of Sequential vs. Simultaneous Adrenal Vein Sampling | Yahao Zhang | Observational | Completed | Primary Aldosteronism, Hypertension | 238 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918781 | Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG | China National Center for Cardiovascular Diseases | Not applicable | Not yet recruiting | Postoperative Atrial Fibrillation, Coronary Artery Disease | 1,470 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918755 | Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features | Zhongshan People's Hospital, Guangdong, China | Observational | Not yet recruiting | Nasopharyngeal Carcinoma (NPC) | 1,500 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918625 | A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes | BrightGene Bio-Medical Technology Co., Ltd. | Phase 2 | Not yet recruiting | Overweight or Obese Participants Without Diabetes | 160 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918456 | A Phase I Clinical Trial of CPU-YL01 Injection in Patients With Chronic Hepatitis B. | Jiangsu Chuangyuan Life Science and Technology Co., Ltd. | Phase 1 | Enrolling by invitation | Chronic Hepatitis B | 74 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918235 | Spatial Needle Placement Strategies and Pathological Concordance in Prostate Biopsy: A National Multicenter Retrospective Cohort Study | Guangxi Medical University | Observational | Active not recruiting | Prostate Cancer, Prostatic Neoplasms | 30,000 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918222 | Sequential Treatment Approaches for Treatment-Resistant Schizophrenia | Shanghai Mental Health Center | Phase 3 | Recruiting | Treatment-resistant Schizophrenia | 300 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07918053 | A Prospective Study of Rimegepant for Short-term Preventive Treatment of Night-shift-related Migraine in Healthcare Professionals | Chinese PLA General Hospital | Not applicable | Not yet recruiting | Migraine Disorders | 260 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07917962 | Foraminal Imaging and Symptoms in Single-Level Degenerative Lumbar Stenosis | The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | Observational | Not yet recruiting | Degenerative Lumbar Spinal Stenosis, Lumbar Foraminal Stenosis | 120 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07917949 | Zemetostat With Anlotinib in Patients With Recurrent/Metastatic Head and Neck Soft Tissue Sarcoma | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 | Recruiting | Soft Tissue Sarcoma | 34 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07917923 | A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Refractory Generalized Myasthenia Gravis | Daishi Tian | Early phase 1 | Not yet recruiting | Generalized Myasthenia Gravis (gMG) | 12 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07917897 | Individualized Inspired Oxygen Fraction Titration During Lung Surgery (iOXY-LUNG) | Shanghai Pulmonary Hospital, Shanghai, China | Not applicable | Not yet recruiting | Postoperative Complications | 628 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07917806 | A RCT of Collagen Scaffold for the Repair of Talus Cartilage Injury | Beijing Jishuitan Hospital | Phase 3 | Enrolling by invitation | Cartilage Defects, Talus Osteochondral Defect | 40 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917650 | PET/CT-Guided Maintenance Therapy in Previously Untreated MZL | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Active not recruiting | Marginal Zone Lymphoma(MZL) | 45 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917624 | Prophylactic Strategies for Mitigating Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Not yet recruiting | Diffuse Large B-Cell Lymphoma (DLBCL) | 87 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917468 | Sintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal Cancer | Innovent Biologics (Suzhou) Co. Ltd. | Phase 3 | Not yet recruiting | Locally Advanced Rectal Cancer | 500 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917429 | Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC | Fujian Medical University Union Hospital | Observational | Not yet recruiting | Colorectal Cancer Metastatic | 610 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917351 | AI-Assisted Whole-Course Management for Medication Safety and Healthcare Burden in Advanced Solid Tumors: A Prospective Controlled Study | Tianjin Medical University Second Hospital | Not applicable | Recruiting | Digital Health, Artificial Intelligence (AI) | 420 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917182 | Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations... | Chinese University of Hong Kong | Observational | Not yet recruiting | Alzheimer s Disease, Mild Cognitive Impairment (MCI) | 1,600 | China | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 291 | November 6, 2026 |
| Fudan University | 290 | November 6, 2026 |
| Sun Yat-sen University | 264 | November 9, 2026 |
| Ruijin Hospital | 214 | November 9, 2026 |
| Peking Union Medical College Hospital | 198 | November 9, 2026 |
| Beijing Tiantan Hospital | 166 | November 4, 2026 |
| West China Hospital | 165 | November 3, 2026 |
| The First Affiliated Hospital with Nanjing Medical University | 151 | November 3, 2026 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 148 | November 5, 2026 |
| Institute of Hematology & Blood Diseases Hospital, China | 146 | November 5, 2026 |
| Shanghai Zhongshan Hospital | 143 | November 5, 2026 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 141 | November 4, 2026 |
| Peking University People's Hospital | 139 | November 9, 2026 |
| Tianjin Medical University Cancer Institute and Hospital | 136 | November 4, 2026 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 120 | November 5, 2026 |
| Chinese PLA General Hospital | 117 | November 5, 2026 |
| Peking University First Hospital | 115 | November 4, 2026 |
| Xuanwu Hospital, Beijing | 114 | November 9, 2026 |
| Tongji Hospital | 112 | November 4, 2026 |
| Peking University Third Hospital | 112 | October 30, 2026 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 412 | November 6, 2026 |
| Breast Neoplasms | 388 | November 9, 2026 |
| Obesity | 275 | November 9, 2026 |
| Colorectal Neoplasms | 267 | November 9, 2026 |
| Stomach Neoplasms | 250 | November 9, 2026 |
| Carcinoma, Hepatocellular | 239 | November 5, 2026 |
| Lung Neoplasms | 227 | November 4, 2026 |
| Ischemic Stroke | 227 | November 3, 2026 |
| Diabetes Mellitus, Type 2 | 194 | November 6, 2026 |
| Neoplasms | 192 | November 6, 2026 |
| Overweight | 187 | November 9, 2026 |
| Recurrence | 186 | November 6, 2026 |
| Prostatic Neoplasms | 155 | November 9, 2026 |
| Stroke | 148 | November 9, 2026 |
| Pancreatic Neoplasms | 145 | November 9, 2026 |
| Leukemia, Myeloid, Acute | 130 | November 9, 2026 |
| Atrial Fibrillation | 120 | November 9, 2026 |
| Lupus Erythematosus, Systemic | 118 | October 28, 2026 |
| Coronary Artery Disease | 116 | November 5, 2026 |
| Multiple Myeloma | 116 | November 3, 2026 |
| Disease | 110 | November 3, 2026 |
| Small Cell Lung Carcinoma | 108 | November 4, 2026 |
| Cognitive Dysfunction | 104 | November 4, 2026 |
| Esophageal Neoplasms | 104 | October 29, 2026 |
| Rectal Neoplasms | 94 | November 6, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 4,282 | November 9, 2026 |
| Observational | 3,275 | November 9, 2026 |
| Phase 2 | 2,502 | November 9, 2026 |
| Phase 1 | 1,543 | November 9, 2026 |
| Phase 3 | 1,259 | November 9, 2026 |
| Phase 1/2 | 802 | November 9, 2026 |
| Phase 4 | 497 | November 9, 2026 |
| Early phase 1 | 433 | November 6, 2026 |
| Phase 2/3 | 180 | November 9, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.